Hemodialysis-associated induction of cytokines

被引:0
|
作者
Schindler, R [1 ]
机构
[1] Humboldt Univ, Klinikum Charite, Abt Nephrol & Internist Intens Med, D-13353 Berlin, Germany
关键词
biocompatibility; hemodialysis; interleukin; 1; cytokines; complement; endotoxin; mortality;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
A number of studies demonstrated an induction of cytokines during hemodialysis; possible mechanisms are complement factors activated on the membrane and bacterial products from the dialysate. When comparing the permeability of different membranes regarding bacterial products, several issues have to be perceived: the limulus-test is not sufficient for detection of bacterial products, cytokine induction is a better parameter. Synthetic membranes adsorb bacterial products. The plasma protein layer on the membrane prevents penetration of bacterial products from the dialysate. When using complement-activating membranes, there is a synergism between complement and bacterial products on cytokine induction. In vivo studies demonstrated that pyrogen-free, ultrafiltered dialysate as well as the use of "biocompatible" membranes reduce cytokine induction and the inflammatory reaction in dialysis patients. The long-term clinical consequences of pyrogen-free dialysate and "biocompatible" membranes are not proven yet; a repetitive induction of cytokines may have detrimental effects on beta(2)-amyloidosis and cardiovascular complications in dialysis patients.
引用
收藏
页码:36 / 41
页数:6
相关论文
共 50 条
  • [1] HEMODIALYSIS-ASSOCIATED INDUCTION OF CYTOKINES
    LONNEMANN, G
    HAUBITZ, M
    SCHINDLER, R
    BLOOD PURIFICATION, 1990, 8 (04) : 214 - 222
  • [2] Clinical relevance of hemodialysis-associated induction of cytokines
    Lonnemann, G
    NIEREN-UND HOCHDRUCKKRANKHEITEN, 1999, 28 (02) : 49 - 55
  • [3] EXPRESSION OF INFLAMMATORY CYTOKINES AND ADHESION MOLECULES IN HEMODIALYSIS-ASSOCIATED AMYLOIDOSIS
    INOUE, H
    SAITO, I
    NAKAZAWA, R
    MUKAIDA, N
    MATSUSHIMA, K
    AZUMA, N
    SUZUKI, M
    MIYASAKA, N
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1995, 10 (11) : 2077 - 2082
  • [4] HEMODIALYSIS-ASSOCIATED HEPATITIS
    GARIBALDI, RA
    FORREST, JN
    BRYAN, JA
    HANSON, BF
    DISMUKES, WE
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1973, 225 (04): : 384 - 389
  • [5] HEMODIALYSIS-ASSOCIATED HYPOXEMIA
    GARELLA, S
    CHANG, BS
    AMERICAN JOURNAL OF NEPHROLOGY, 1984, 4 (05) : 273 - 279
  • [6] HEMODIALYSIS-ASSOCIATED MUSCLE CRAMPS
    CANZANELLO, VJ
    BURKART, JM
    SEMINARS IN DIALYSIS, 1992, 5 (04) : 299 - 304
  • [7] LACK OF HEMODIALYSIS-ASSOCIATED AMYLOIDOSIS
    ZINGRAFF, J
    BARDIN, T
    NOEL, LH
    DRUEKE, T
    LANCET, 1991, 338 (8774): : 1089 - 1089
  • [8] METARAMINOL FOR HEMODIALYSIS-ASSOCIATED PRIAPISM
    BRANGER, B
    RAMPEREZ, P
    OULES, R
    BALDUCCHI, JP
    FOURCADE, J
    SHALDON, S
    COSTA, P
    LOUIS, JF
    NAVRATIL, H
    LANCET, 1985, 1 (8429): : 641 - 641
  • [9] HEMODIALYSIS-ASSOCIATED HEMORRHAGIC CHOLECYSTITIS
    MCFADDEN, DW
    SMITH, GW
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 1987, 82 (10): : 1081 - 1083
  • [10] Case Report of Hemodialysis-Associated Thrombocytopenia
    Suleiman, Samah S.
    Ghandour, Mohamedanwar M.
    Jawed, Areeba
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 799 - 799